St Louis, MONCT05685485Now EnrollingIRB Ready

Glaucoma Eye Clinical Trial in St Louis, MO

Access cutting-edge glaucoma eye treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.

Sponsored by Washington University School of Medicine

Quick Self-Assessment

See if you qualify for this St Louis location

Preparing your pre-screening questions…

Expert Care in St Louis

Access glaucoma eye specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related glaucoma eye treatment provided free

Apply for This St Louis Location

Check if you qualify for this glaucoma eye clinical trial in St Louis, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to St Louis

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit St Louis site if eligible
  4. 4Begin participation

About This Glaucoma Eye Study in St Louis

The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable outcome. To assess this the investigator will conduct a, randomized prospective, multi-centered study with collaborators at WashU in St. Louis, Duke University, Indiana University and the University of Pittsburgh. Participants will be randomized to have an AGV placement with tube ligation (no-early flow) and without ligation (allowing for early flow). IOP will be measured at day one, week one, and months, one, three six, and twelve. Additionally, clinical data regarding number of glaucoma medications, and complications post-operative complications will also be collected.

Sponsor: Washington University School of Medicine

Who Can Participate

Inclusion Criteria

Subjects with age at screening ≥ 18 years
Inadequately controlled glaucoma or ocular hypertension
Ahmed valve implant as the planned surgical procedure
Patients with primary glaucomas (Primary Open Angle Glaucoma or Primary Angle Closure Glaucoma) or pseudoexfoliation, pigmentary and traumatic glaucoma with or without a previous failed trabeculectomy or other intraocular surgery.
Primary tubes included
Investigators to recruit consecutively all eligible patients from their clinics.
Capable and willing to provide consent

Exclusion Criteria

Subjects with NLP vision
Subjects unable/unwilling to provide informed consent
Unavailable for regular follow up
Previous cyclodestructive procedure
Prior scleral buckling procedure or other external impediment to drainage device implantation
Presence of silicone oil
Vitreous in the anterior chamber sufficient to require a vitrectomy
Uveitic glaucoma
Neovascular glaucoma
Nanophthalmos
Patients with pathology that may cause elevated episcleral venous pressure
Procedure combined with ocular surgery other than cataract surgery (i.e. combined tube-cataract surgery is okay)
Any abnormality other than glaucoma in the study eye that could affect tonometry.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in St Louis?

Yes, this clinical trial (NCT05685485) has an active research site in St Louis, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Glaucoma Eye Treatment Options in St Louis, MO

If you're searching for glaucoma eye treatment options in St Louis, MO, this clinical trial (NCT05685485) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glaucoma eye specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all glaucoma eye clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in St Louis, MO

See all ulcerative colitis clinical trials recruiting in St Louis — not just this study.

Browse Ulcerative Colitis Trials in St Louis

Ready to Join in St Louis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · St Louis, MO